Clover Health Investments
CLOV
225 hedge funds and large institutions have $763M invested in Clover Health Investments in 2026 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 77 increasing their positions, 54 reducing their positions, and 25 closing their positions.
240% more capital invested
Capital invested by funds: $225M → $763M (+$538M)
164% more call options, than puts
Call options by funds: $63.6M | Put options by funds: $24.1M
80% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 25
43% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 54
8% more funds holding
Funds holding: 208 → 225 (+17)
4.11% more ownership
Funds ownership: 29.72% → 33.83% (+4.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nuveen
Charlotte,
North Carolina
|
+$18.2M |
| 2 |
BlackRock
New York
|
+$11.1M |
| 3 |
D.E. Shaw & Co
New York
|
+$6.36M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$5.31M |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$4.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$5.66M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4.61M |
| 3 |
Goldman Sachs
New York
|
-$3.38M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.42M |
| 5 |
Renaissance Technologies
New York
|
-$2.02M |
CLOV Hedge Fund Activity: Q2 2026 in Review
225 of the 8,300 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q2 2026, worth a combined $763M — up 240% from $225M a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new CLOV positions and 25 closed out — a net gain of 20 holders — while 77 added to existing stakes and 54 trimmed.
The largest buyer was Nuveen, adding an estimated $18.2M. The largest seller was HRT Financial, exiting entirely with an estimated $5.66M sold.
- 225 institutional investors held Clover Health Investments (CLOV) as of Q2 2026, up from 208 in Q1 2026.
- Funds reported $763M of Clover Health Investments stock for Q2 2026, up 240% quarter-over-quarter.
- 45 funds opened new Clover Health Investments positions in Q2 2026 and 25 closed out, a net change of +20 holders.
- The largest Clover Health Investments buyer in Q2 2026 was Nuveen, an estimated $18.2M added.
- The largest Clover Health Investments seller in Q2 2026 was HRT Financial, an estimated $5.66M sold.
Based on aggregated 13F filings for Q2 2026.